human | Q5 |
P496 | ORCID iD | 0000-0002-9338-0051 |
P69 | educated at | Kyushu University | Q1188786 |
P108 | employer | First Affiliated Hospital, China Medical University | Q17014231 |
P735 | given name | Han | Q19810530 |
Han | Q19810530 | ||
P106 | occupation | researcher | Q1650915 |
Q34797862 | A Novel Platelet-Activating Factor Receptor Antagonist Inhibits Choroidal Neovascularization and Subretinal Fibrosis |
Q33425973 | Antiangiogenic immunotherapy targeting Flk-1, DNA vaccine and adoptive T cell transfer, inhibits ocular neovascularization |
Q100526042 | Assessment of conbercept therapy for high myopia macular neovascularization by optical coherence tomography angiography |
Q91158164 | Conbercept and Ranibizumab Pretreatments in Vitrectomy with Silicone Oil Infusion for Severe Diabetic Retinopathy |
Q101051612 | Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells |
Q104681299 | Effects of the COVID-19 Pandemic on Anti-vascular Endothelial Growth Factor Treatment in China |
Q33607728 | Interleukin-13 and age-related macular degeneration |
Q33595468 | Prevalence and causes of low vision and blindness in Baotou: A cross-sectional study |
Search more.